$kpti
KPTI is seeing a massive surge in engagements, up 258% from its daily average, with sentiment also climbing 300% week-over-week. This spike is driven by discussions around biotech catalysts and growth performers, though high implied volatility in options adds a layer of market uncertainty.
About $kpti
$kpti refers to Kernel Page Table Isolation, a security feature in operating systems.
Insights
- $kpti mentions hit [---] which is 302% higher than it's daily average.
- $kpti engagements hit 23.3K which is 258% higher than it's daily average.
- $kpti creators hit [---] which is 352% higher than it's daily average.
- $kpti sentiment is up 32% from the previous week.
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [---] -36%
[--] Month: [-------] -12%
[--] Months: [-------] -0.14%
[--] Year: [---------] +244%
1-Year High: [-------] on 2025-02-19
1-Year Low: [--] on 2025-09-22
Engagements by network (24h): Reddit: [--] X: [------]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
1-Year High: [---] on 2025-06-30
1-Year Low: [--] on 2025-09-22
Mentions by network (24h): Reddit: [--] X: [---]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning $kpti in the last [--] hours which is up 589% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-30
1-Year Low: [--] on 2025-09-22
The most influential creators that mention $kpti in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [------] |
| @semodough | [--] | [------] | [--] | [-----] |
| @kinatsofrim | [--] | [---] | [--] | [---] |
| @BPharmCatalyst | [--] | [------] | [--] | [---] |
| @stocket_rocket | [--] | [--] | [--] | [--] |
| @MinervaCap | [--] | [-----] | [--] | [--] |
| @Stocktology | [--] | [---] | [--] | [--] |
| @BuyTheUgly | [--] | [-----] | [--] | [--] |
| @OzmosiHealth | [--] | [-----] | [--] | [--] |
| @AmberLCox | [--] | [-----] | [--] | [--] |
Sentiment: 65%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 65%
Daily Average: 75%
[--] Week: 33% +8%
[--] Month: 60% +3%
[--] Months: 60% -40%
[--] Year: 60% -40%
1-Year High: 100% on 2025-02-20
1-Year Low: 6% on 2025-12-26
Most Supportive Themes:
- Biotech Stock Catalyst Watchlist: (40%) This theme focuses on upcoming clinical trial readouts for biotechnology companies, indicating potential breakthroughs or setbacks in drug development.
- Biopharma Weekly Recap: (30%) This theme summarizes key events and trends in the biopharmaceutical industry, including M&A activity and advancements in drug discovery.
- Top Growth Performers: (30%) This theme highlights companies that have shown significant stock price appreciation, suggesting strong market performance and investor confidence.
Most Critical Themes:
- Highest Implied Volatility Options: (100%) This theme identifies options with high implied volatility, suggesting increased market uncertainty and potential for significant price swings in the underlying assets.
Top $kpti Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"🧬 Biopharma Weekly Recap 📝 This week in biotech: $NKTR AtD data and financing ignite upside debate GLP-1 pill surge boosts $NVO/$LLY M&A chatter builds and dense Q1 readouts drive volatility. See interesting posts/ppl to check out 👇 @AppleHelix 1/ There is some confusion with the reporting on $MRNA Refuse to File. @seedy19tron The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt @Andre_AGTC My watch list near term catalysts @ResearchPulse1 Can UBT251 from NVO be a"
X Link @BiopharmIQ 2026-02-14T16:03Z 28.9K followers, 11.5K engagements
"BioPharmCatalyst Weekly #Watchlist BioPharmCatalyst Weekly Watchlist: Key Phase [--] catalysts left for the quarter $OCUL $BCRX $GOSS $BCDA $KOD $TBPH $KPTI $PVLA https://www.biopharmcatalyst.com/news/2026/biopharmcatalyst-weekly-watchlist-key-phase-3-catalysts-left-for-the-quarter https://www.biopharmcatalyst.com/news/2026/biopharmcatalyst-weekly-watchlist-key-phase-3-catalysts-left-for-the-quarter"
X Link @BPharmCatalyst 2026-02-13T21:33Z 30.7K followers, [----] engagements
"$KPTI LR given $KPTI's constrained cash runway. remain on the sidelines awaiting more durable growth trends on Xpovio sales convincing evidence that Xpovio sales growth will not be overshadowed by existing operating expenses and a clearer picture on the potential opportunities for Xpovio beyond multiple myeloma. Reiterate MP. PT$6 $KPTI with cash concern & dilution - $KPTI all ready has [---] million in Debt also $KPTI with cash concern & dilution - $KPTI all ready has [---] million in Debt also"
X Link @semodough 2026-02-13T14:20Z 42.5K followers, [----] engagements
"$KPTI with cash concern & dilution - $KPTI all ready has [---] million in Debt also $KPTI its even worse than I thought - only [--] million cash left as Dec [--]. Less then [--] quarters going into some high risk data sets. $KPTI has terrible history. Careful /Dilution is coming soon & not sure it be the good kind $KPTI its even worse than I thought - only [--] million cash left as Dec [--]. Less then [--] quarters going into some high risk data sets. $KPTI has terrible history. Careful /Dilution is coming soon & not sure it be the good kind"
X Link @semodough 2026-02-13T11:59Z 42.5K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing